BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 579835)

  • 41. Detailed analysis of menstrual bleeding patterns after postmenstrual and postabortal insertion of a copper IUD or a levonorgestrel-releasing intrauterine system.
    Suvisaari J; Lähteenmäki P
    Contraception; 1996 Oct; 54(4):201-8. PubMed ID: 8922872
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Intrauterine devices].
    Delavest P; Engelmann P
    Rev Prat; 1980 Dec; 30(57):3981-2, 3985-7. PubMed ID: 7455547
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Influences of copper and design of intrauterine devices on endometrial bleeding in monkeys.
    Shaw ST; Forino RV; Poon CH; Moyer DL
    Contraception; 1976 Jul; 14(1):9-15. PubMed ID: 824096
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intrauterine device developments.
    Netw Res Triangle Park N C; 1984; 5(4):4-6. PubMed ID: 12313225
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Actinomyces-like structures and their association with intrauterine contraceptive devices, pelvic infection and abnormal cervical cytology.
    Sykes GS; Shelley G
    Br J Obstet Gynaecol; 1981 Sep; 88(9):934-7. PubMed ID: 7272267
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dimensional and architectural disproportion between the intrauterine device and the uterine cavity. A casue of bleeding.
    Kamal I; Hefnawi F; Ghoneim M; Talaat M; Abdalla M
    Fertil Steril; 1971 Aug; 22(8):514-21. PubMed ID: 5164979
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Concentrations of copper in human secretions and weight of the copper wire during the 4 to 7 years after insertion of a Cu-IUD (intrauterine device).
    Larsson B; Frankman O; Hamberger L
    Fertil Steril; 1981 Dec; 36(6):734-6. PubMed ID: 7308517
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Should endometrial hyperplasia be regarded as a reason for abnormal uterine bleeding in users of the intrauterine contraceptive device?
    Ozalp S; Kabukcuoglu S; Tanir HM
    Eur J Contracept Reprod Health Care; 2003 Mar; 8(1):17-20. PubMed ID: 12725671
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intrauterine device use and endometrial cancer risk.
    Sturgeon SR; Brinton LA; Berman ML; Mortel R; Twiggs LB; Barrett RJ; Wilbanks GD; Lurain JR
    Int J Epidemiol; 1997 Jun; 26(3):496-500. PubMed ID: 9222773
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Statement on intrauterine devices (IUDs).
    International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP
    IPPF Med Bull; 1987 Dec; 21(6):3-5. PubMed ID: 12268853
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interactions between intrauterine contraceptive device use and breast-feeding status at time of intrauterine contraceptive device insertion: analysis of TCu-380A acceptors in developing countries.
    Farr G; Rivera R
    Am J Obstet Gynecol; 1992 Jul; 167(1):144-51. PubMed ID: 1442918
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Copper T 220C: a new long-acting copper intrauterine contraceptive device.
    Cooper DL; Millen AK; Mishell DR
    Am J Obstet Gynecol; 1976 Jan; 124(2):121-4. PubMed ID: 1247047
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Menstrual blood loss, haemoglobin and ferritin concentration of Beijing women wearing steel ring, VCu 200, and TCu 220c IUDs.
    Gao J; Zeng S; Sun BL; Wu SC; Dong J; Cong J; Zhu XH; Fan HM; Han LH; Xie Z
    Contraception; 1986 Dec; 34(6):559-71. PubMed ID: 3829674
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A simple technic of hysterography for evaluating side effects and mode of action of intrauterine devices. A study of 100 cases.
    Mazher K; Kamal I; Hefnawi F; Talaat M; Younis N; Tagi AE
    Fertil Steril; 1967; 18(3):353-66. PubMed ID: 6024079
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Endometrial cytology and copper containing intrauterine devices].
    Herting W; Tauber PF
    Fortschr Med; 1978 Feb; 96(7):311-4. PubMed ID: 304829
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intrauterine devices. The optimal long-term contraceptive method?
    Fortney JA; Feldblum PJ; Raymond EG
    J Reprod Med; 1999 Mar; 44(3):269-74. PubMed ID: 10202746
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of three different models of the copper T intrauterine contraceptive device.
    Roy S; Casagrande J; Cooper DL; Mishell DR
    Am J Obstet Gynecol; 1979 Jul; 134(5):568-74. PubMed ID: 453297
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Comparative study on the clinical effects and endometrial findings of IUD].
    Chao CK
    Toho Igakkai Zasshi; 1988 Mar; 34(6):550-60. PubMed ID: 12343145
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The effect of intrauterine contraceptive devices on the endometrium].
    Sheppard BL; Bonnar J
    Contracept Fertil Sex (Paris); 1987 Nov; 15(11):1015-24. PubMed ID: 12341565
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Complications of use of intrauterine devices among HIV-1-infected women.
    Sinei SK; Morrison CS; Sekadde-Kigondu C; Allen M; Kokonya D
    Lancet; 1998 Apr; 351(9111):1238-41. PubMed ID: 9643743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.